Observational Study of Muscle Invasive Urothelial Carcinoma Participants Treated With Adjuvant Nivolumab in France

NCT06421311 · clinicaltrials.gov ↗
TERMINATED
Status
176
Enrollment
INDUSTRY
Sponsor class

Stopped Business objectives have changed

Conditions

Interventions

Sponsor

Bristol-Myers Squibb